Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ME Therapeutics Logo
ME Therapeutics Growth Score
57
CB Rank
50856
Heat Score
74
ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.
Founded
obfuscation
PublicPost-IPO Equity Vancouver, British Columbia, Canada11-50 www.metherapeutics.com/
Biopharma
Biotechnology
Life Science
Therapeutics
Overview

ME Therapeutics
Total Funding
obfuscation
Growth Score
57
Heat Score
74

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score57
-19 pts
in past quarter
Heat Score 74
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About ME Therapeutics

CB Rank
50856
ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.
Founded
obfuscation
PublicPost-IPO Equity Vancouver, British Columbia, Canada11-50 www.metherapeutics.com/
Biopharma
Biotechnology
Life Science
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name ME Therapeutics Holdings Inc.
Also Known As ME Therapeutics Holdings, Myeloid Enhancement (ME) Therapeutics, Myeloid Enhancement Therapeutics, METX Research Corp, ME Therapeutics Inc.
Operating Status Active
Stock Symbol  CSE:METX
Company Type For Profit
Founders  Salim Dhanji
About the Company
ME Therapeutics is a biotechnology company that focuses on discovery and development of Myeloid cell targeted immuno oncology drugs.
Predictions & Insights

Growth Insight

See this Growth Insight
ME Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Anti-G-CSF Antibody Candidate
A humanized antibody targeting granulocyte-colony stimulating factor (G-CSF) to treat cancer by modulating immune suppression.
mRNA Therapeutic Candidates
mRNA-based drug candidates designed to target myeloid cells for cancer and inflammatory disease treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - ME Therapeutics Logo
Post-IPO Equity - ME Therapeutics
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

516
892.31%
 in past month

IT Spend

$73KThis year, ME Therapeutics is projected to spend $73K on IT, according to Aberdeen.

Active Website Tech Count

10ME Therapeutics is actively using 10 technologies for its website, according to BuiltWith. These include SSL by Default, U.S. Server Location, and  Euro.

Total IP

1ME Therapeutics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ME Therapeutics's headquarters? ME Therapeutics is located in Vancouver, British Columbia, Canada.Who invested in ME Therapeutics? ME Therapeutics is funded by National Research Council of Canada Industrial Research Assistance Program.When was the last funding round for ME Therapeutics? ME Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are ME Therapeutics's competitors? Alternatives and possible competitors to ME Therapeutics may include Anaveon, Strand Therapeutics, and  Flashpoint Therapeutics.How much funding has ME Therapeutics raised to date? ME Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|